Simvastatin Tablet, Film Coated
Product Images NDC 71335-1906

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Simvastatin (NDC 71335-1906). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Footnote For Table 3 (Footnote For Table 3)

Results obtained from a chemical assay indicate potential inhibitors of CYP3A4 enzyme which include Ketoconazole, erythromycin, clarithromycin, HIV protease inhibitors, and nefazodone. The text also explains that simvastatin acid refers to the p-hydroxyacid of simvastatin, but the effect of grapefruit juice on simvastatin pharmacokinetics is not established. Grapefruit juice was used in different amounts in two studies along with single or multiple doses of simvastatin. The text also mentions that the results exclude those with propranolol.*

FDA Label Image

Label (Lbl713351906)

The text appears to be a medication label for Simvastatin, a drug used to lower cholesterol and triglycerides in the blood. It specifies that the tablet is pink and oval-shaped with the marking "B303;40" and contains 40mg of the drug. It provides instructions to store the medication at room temperature and to keep all drugs out of reach of children. There are also details about the manufacturer, expiration date, and NDC (National Drug Code).*

FDA Label Image

Figure 9 (Simvastatin 10)

FDA Label Image

Table2 (Simvastatin 2)

This is a table showing Adverse Reactions reported by patients treated with Simvastatin compared to Placebo. The table lists the percentage of patients experiencing different types of disorders that are greater than placebo in 45 individuals. The disorders mentioned in the table include Edema/swelling, Abdominal pain, Atrial fibrillation, Constipation, Gastritis, Diabetes mellitus, Myalgia, Headache, Insomnia, Vertigo, Bronchitis, Sinusitis, Eczema, and Urinary tract infections.*

FDA Label Image

Structure (Simvastatin 3)

FDA Label Image

Table 3 (Simvastatin 4)

FDA Label Image

Table 4 (Simvastatin 5)

FDA Label Image

Figure 5 (Simvastatin 6)

Not available.*

FDA Label Image

Figure 6 (Simvastatin 7)

FDA Label Image

Figure 7 (Simvastatin 8)

FDA Label Image

Figure 8 (Simvastatin 9)

FDA Label Image

Table 1 (Table1)

The given text seems to be a table of "Drug Interactions Associated with an Increased Risk of Myopathy/Rhabdomyolysis". It lists different drugs that are known to increase the risk of Myopathy when taken with simvastatin (a type of medication used to lower cholesterol levels in the blood). The table offers prescribing recommendations or advises to avoid exceeding the recommended dosage for each interacting agent. However, the last line appears to be scrambled and is not coherent.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.